DIGITOME

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke DIGITOME wurde als Wortmarke am 28.09.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 15. November 2021

Markenform Wortmarke
Aktenzeichen 1578035
Registernummer 6010838
Länder Europäische Gemeinschaft
Basismarke US Nr. 6010838, 17. März 2020
Anmeldedatum 28. September 2020
Ablaufdatum 28. September 2030

Markeninhaber

555 BRYANT ST. #561
PALO ALTO CA 94301
US

Markenvertreter

525 UNIVERSITY AVENUE, A70 PALO ALTO CA 94301 US

Waren und Dienstleistungen

42 Software as a service (SaaS) services, namely, hosting software for use by others for use for disease progression prediction; software as a service (SaaS) services, namely, hosting software for use by others for use for medical status assessment; software as a service (SaaS) services, namely, hosting software for use by others for use for overall health assessment; software as a service (SaaS) services, namely, hosting software for use by others for use to determine effective therapies and medications; software as a service (SaaS) services, namely, hosting software for use by others for use to make medical decisions; application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of human health and disease data; application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of genetic data; application service provider (ASP) featuring software for use to derive insights and or understanding about human health and disease; application service provider (ASP) featuring software for use for predictive analytics; application service provider (ASP) featuring software for use for disease progression prediction; application service provider (ASP) featuring software for use for medical status assessment; application service provider (ASP) featuring software for use for overall health assessment; application service provider (ASP) featuring software for use to determine effective therapies and medications; application service provider (ASP) featuring software for use to make medical decisions; application service provider (ASP) featuring software for use to assist in overall medical and therapeutic decision making; conducting clinical trials for others; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; medical and scientific research, namely, conducting clinical trials for others; platform as a service (PaaS) featuring computer software platforms for use in the collection, processing, storage and exchange of human health and disease data; platform as a service (PaaS) featuring computer software platforms for use in the collection, processing, storage and exchange of genetic data; platform as a service (PaaS) featuring computer software platforms for use to derive insights and or understanding about human health and disease; platform as a service (PaaS) featuring computer software platforms for predictive analytics; platform as a service (PaaS) featuring computer software platforms for disease progression prediction; platform as a service (PaaS) featuring computer software platforms for medical status assessment; platform as a service (PaaS) featuring computer software platforms for overall health assessment; platform as a service (PaaS) featuring computer software platforms for use to determine effective therapies and medications; platform as a service (PaaS) featuring computer software platforms for use to make medical decisions; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
44 Health care services, namely, providing a database in the field of disease detection and management information and featuring inputting and collection of data and information all for treatment and diagnostic purposes (Terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); health care services, namely, providing a database in the field of disease therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes (Terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes (Terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations)
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
21. Juli 2021 2021/29 Gaz EM Ablehnung
28. September 2020 2021/7 Gaz US Eintragung

ID: 141578035